cardioP Cancer Research Results
cardioP, cardioProtective: Click to Expand ⟱
| Source: |
| Type: |
CardioProtective
|
CRC, Colorectal Cancer: Click to Expand ⟱
Colorectal cancer is a broader term that encompasses both colon and rectal cancer.
|
Scientific Papers found: Click to Expand⟱
*Inflam↓, *antiOx↑, *cardioP↑, *neuroP↑, TumCCA↑, cycD1/CCND1↓, cycE/CCNE↓, CDC2↓, AMPK↝, mTOR↝, Casp8↑, Casp9↑, Cyt‑c↑, TumCMig↓, TumCI↓, EMT↓, MMPs↓, E-cadherin↓, Telomerase↓, *toxicity↓, GRP78/BiP↓, EGFR↓, CDK4↓, COX2/PTGS2↓, PGE2↓, p‑JAK2↓, p‑STAT3↓, MMP2↓, MMP9↓, GutMicro↑, eff↝, *BioAv↓, BioAv↑,
| - |
vitro+vivo, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
angioG↓, VEGF↓, TumVol↓, Apoptosis↑, HSP60/HSPD1↓, HTRA↓, survivin↓, XIAP↓, P21↑, *toxicity↓, *neuroP↑, *ROS↓, *COX2/PTGS2↓, *Inflam↓, *cardioP↑, AntiCan↑, ChemoSen↑, ROS↑, MMP↑, Bax:Bcl2↑, TumCG↓,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Nor, |
HDFa |
|
|
|
*antiOx↑, *cardioP↑, *neuroP↑, selectivity↑, selectivity↓, TumCCA↑, ROS↑, mtDam↑,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
CRC, |
HT-29 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
ChemoSen↑, TumCP↓, chemoP↑, *ROS↓, *mtDam↓, *Apoptosis↓, *cardioP↑, *NRF2↑, *TGF-β↑, *p‑JNK↓, *p‑p38↓, *MAPK↝, *Akt↝, *STAT3↝,
AntiCan↑, TumCP↓, TumCI↓, Inflam↓, angioG↓, ROS↑, Apoptosis↑, ChemoSen↑, Risk↓, *antiOx↑, *Inflam↓, *AntiBio↑, *cardioP↑, *neuroP↑, selectivity↑, PUMA↑, Cyt‑c↑, cl‑Casp3↑, cl‑PARP↑, Apoptosis↑, NF-kB↓, COX2/PTGS2↓, CC(CDKs/cyclins)↓, TumCCA↑, BioAv↓, eff↑, DR4↑, DR5↑, Casp3↑, Casp9↑, Casp7↑, TumCP↓, TumCI↓, TumAuto↑, mtDam↑, P53↑, MAPK↑, *lipid-P↓, *TAC↑, *Catalase↑, *SOD↑, *GPx↑, *NRF2↑,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
HSP60/HSPD1↓, 1, HTRA↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 3,
Mitochondria & Bioenergetics(tgid=3) ⓘ
CDC2↓, 1, MMP↑, 1, mtDam↑, 2, XIAP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↝, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 3, Bax:Bcl2↑, 1, Casp3↑, 1, cl‑Casp3↑, 1, Casp7↑, 1, Casp8↑, 1, Casp9↑, 2, Cyt‑c↑, 2, DR4↑, 1, DR5↑, 1, MAPK↑, 1, PUMA↑, 1, survivin↓, 1, Telomerase↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
GRP78/BiP↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK4↓, 1, cycD1/CCND1↓, 1, cycE/CCNE↓, 1, P21↑, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
EMT↓, 1, mTOR↝, 1, p‑STAT3↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
CC(CDKs/cyclins)↓, 1, E-cadherin↓, 1, MMP2↓, 1, MMP9↓, 1, MMPs↓, 1, TumCI↓, 3, TumCMig↓, 1, TumCP↓, 3,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 2, EGFR↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 2, Inflam↓, 1, p‑JAK2↓, 1, NF-kB↓, 1, PGE2↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 1, ChemoSen↑, 3, eff↑, 1, eff↝, 1, selectivity↓, 1, selectivity↑, 2,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 1, GutMicro↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 2, chemoP↑, 1, Risk↓, 1, TumVol↓, 1,
Total Targets: 64
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiBio↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 3, Catalase↑, 1, GPx↑, 1, lipid-P↓, 1, NRF2↑, 2, ROS↓, 2, SOD↑, 1, TAC↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
mtDam↓, 1,
Cell Death(tgid=5) ⓘ
Akt↝, 1, Apoptosis↓, 1, p‑JNK↓, 1, MAPK↝, 1, p‑p38↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
STAT3↝, 1,
Migration(tgid=13) ⓘ
TGF-β↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, Inflam↓, 3,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1,
Functional Outcomes(tgid=23) ⓘ
cardioP↑, 5, neuroP↑, 4, toxicity↓, 2,
Total Targets: 23
Scientific Paper Hit Count for: cardioP, cardioProtective
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:6 Cells:% prod#:% Target#:1188 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page